Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

Fractional exhaled nitric oxide and the peripheral blood eosinophil count as biomarkers of the response to mepolizumab in patients with severe eosinophilic asthma

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Shrimanker, R, Pavord, I, Price, R, Bradford, E, Keene, O, Yancey, S
Формат:	Conference item
Хэвлэсэн:	American Thoracic Society 2018

Ижил төстэй зүйлс

Prognostic and predictive value of blood eosinophil count, fractional exhaled nitric oxide and their combination in severe asthma: a post-hoc analysis
-н: Shrimanker, R, зэрэг
Хэвлэсэн: (2019)

Evaluation of potential continuation rules for mepolizumab treatment of severe eosinophilic asthma.
-н: Gunsoy, N, зэрэг
Хэвлэсэн: (2017)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
-н: Steven W. Yancey, зэрэг
Хэвлэсэн: (2019-09-01)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
-н: Howell, I, зэрэг
Хэвлэсэн: (2024)

Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.
-н: Bel, E, зэрэг
Хэвлэсэн: (2014)

Mepolizumab treatment in patients with severe eosinophilic asthma.
-н: Ortega, H, зэрэг
Хэвлэсэн: (2014)

Glucocorticoids and mepolizumab in eosinophilic asthma.
-н: Bel, E, зэрэг
Хэвлэсэн: (2014)

Mepolizumab in refractory eosinophilic asthma.
-н: Pavord, I, зэрэг
Хэвлэсэн: (2010)

Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
-н: Imran Howell, зэрэг
Хэвлэсэн: (2024-07-01)

Mepolizumab for eosinophilic COPD
-н: Sciurba, F, зэрэг
Хэвлэсэн: (2018)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
-н: Price, D, зэрэг
Хэвлэсэн: (2019)

Meta-analysis of asthma-related hospitalization in mepolizumab studies of severe eosinophilic asthma
-н: Yancey, S, зэрэг
Хэвлэсэн: (2016)

Diagnostic possibility of the combination of exhaled nitric oxide and blood eosinophil count for eosinophilic asthma
-н: Jiang-Hua Li, зэрэг
Хэвлэсэн: (2021-08-01)

Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations
-н: David B. Price, зэрэг
Хэвлэсэн: (2019-08-01)

Mepolizumab, quality of life, and severe eosinophilic asthma.
-н: Pavord, I
Хэвлэсэн: (2017)

Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies.
-н: Ortega, H, зэрэг
Хэвлэсэн: (2016)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
-н: Shrimanker, R, зэрэг
Хэвлэсэн: (2017)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
-н: Haldar, P, зэрэг
Хэвлэсэн: (2009)

Biomarkers for severe eosinophilic asthma.
-н: Yancey, S, зэрэг
Хэвлэсэн: (2017)

Blood eosinophil depletion with mepolizumab, benralizumab and prednisolone in eosinophilic asthma
-н: Moran, AM, зэрэг
Хэвлэсэн: (2020)

Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab
-н: Ian D. Pavord, зэрэг
Хэвлэсэн: (2022-05-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
-н: Shrimanker, R, зэрэг
Хэвлэсэн: (2017)

Targeting the IL-5 pathway in eosinophilic asthma: a comparison of mepolizumab to benralizumab in the reduction of peripheral eosinophil counts
-н: Arian Ghassemian, зэрэг
Хэвлэсэн: (2021-01-01)

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
-н: Shrimanker, R, зэрэг
Хэвлэсэн: (2017)

Mepolizumab for eosinophilic chronic obstructive pulmonary disease
-н: Pavord, I, зэрэг
Хэвлэсэн: (2017)

Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma
-н: Jie Gao, зэрэг
Хэвлэсэн: (2018-05-01)

Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
-н: Terufumi Shimoda, зэрэг
Хэвлэсэн: (2017-07-01)

Does a composite score combining peripheral blood eosinophils (PBE) and exhaled nitric oxide (FeNO) accurately predict a sputum eosinophilia?
-н: Connolly, CM, зэрэг
Хэвлэсэн: (2017)

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
-н: Pavord, I, зэрэг
Хэвлэсэн: (2012)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
-н: Prazma CM, зэрэг
Хэвлэсэн: (2021-06-01)

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma
-н: Gao J, зэрэг
Хэвлэсэн: (2018-04-01)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
-н: Menzella F, зэрэг
Хэвлэсэн: (2016-06-01)

Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
-н: Pavord, I, зэрэг
Хэвлэсэн: (2017)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
-н: Charlene M. Prazma, зэрэг
Хэвлэсэн: (2019-05-01)

Blood eosinophil phenotype during treatment with mepolizumab in patients with severe eosinophilic asthma
-н: Chio Sakai, зэрэг
Хэвлэсэн: (2024-07-01)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
-н: Berry, M, зэрэг
Хэвлэсэн: (2005)

Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
-н: Wechsler, M, зэрэг
Хэвлэсэн: (2017)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
-н: Buendía, JA, зэрэг
Хэвлэсэн: (2022)

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis
-н: Jefferson Antonio Buendía, зэрэг
Хэвлэсэн: (2022-06-01)

Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts
-н: Yuki Hoshino, зэрэг
Хэвлэсэн: (2022-04-01)